{"id":170087,"date":"2025-08-12T07:58:11","date_gmt":"2025-08-12T11:58:11","guid":{"rendered":"https:\/\/44.250.171.167\/?p=170087"},"modified":"2025-08-12T07:58:11","modified_gmt":"2025-08-12T11:58:11","slug":"zydus-lifesciences-q1-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-q1-fy26-earnings-results\/","title":{"rendered":"Zydus Lifesciences Q1 FY26 Earnings Results"},"content":{"rendered":"<p>In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address the unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe. Presenting below are its Q1 FY26 earnings results.<\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"q1-fy26-earnings-summary-apriljune-2025\" class=\"mb-2 mt-4 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\">Q1 FY26 Earnings Results<\/h2>\n<ul class=\"marker:text-quiet list-disc\">\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Revenue from Operations:<\/strong> \u20b96,574 crore, up 5.9% year-over-year (YoY) from \u20b96,207 crore in Q1 FY25, and slightly up 0.7% quarter-on-quarter (QoQ) from \u20b96,527 crore.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Net Profit (PAT):<\/strong> \u20b91,521 crore, a 2.6% increase YoY from \u20b91,420 crore in Q1 FY25, and a strong 25.3% rise QoQ from \u20b91,170 crore in Q4 FY25.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>EBITDA:<\/strong>\u00a0\u20b92,089 crore, nearly flat YoY; EBITDA margin contracted to 31.8% from 33.6% YoY.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Research &amp; Development (R&amp;D):<\/strong>\u00a0\u20b9486 crore, representing 7.4% of revenues.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Capital Expenditure (Capex):<\/strong>\u00a0\u20b9402 crore (organic).<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Earnings Per Share (EPS):<\/strong> \u20b914.5, up by 3.3% on the YoY basis.<\/p>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p id=\"business-segment-performance\" class=\"mb-2 mt-4 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\"><strong>Business Segment Performance<\/strong><\/p>\n<ul class=\"marker:text-quiet list-disc\">\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>India Geography (Formulations + Consumer Wellness):<\/strong>\u00a0\u20b92,374 crore, up 6% YoY.<\/p>\n<ul class=\"marker:text-quiet list-disc\">\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><em>Formulations<\/em>\u00a0grew 8% YoY to \u20b91,520 crore, driven by strong branded formulations with 9% growth led by chronic segment therapies like cardiology, respiratory, anti-infectives, pain management, and oncology.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><em>Consumer Wellness<\/em>\u00a0rose 2% YoY to \u20b9855 crore, showing strong double-digit growth excluding seasonal brands.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>US Formulations:<\/strong>\u00a0\u20b93,182 crore, up 2.9% YoY, with continued launches and approvals supporting growth.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>International Markets Formulations:<\/strong>\u00a0\u20b9727 crore, surged 36.8% YoY, boosted by market expansions.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>APIs (Active Pharmaceutical Ingredients):<\/strong>\u00a0\u20b9158 crore, up 11.3% YoY.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Alliances &amp; Others:<\/strong>\u00a0Declined 27.9% YoY to \u20b927 crore.<\/p>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3 id=\"key-management-commentary--strategic-highlights\" class=\"mb-2 mt-4 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\">Key Management Commentary &amp; Strategic Highlights<\/h3>\n<ul class=\"marker:text-quiet list-disc\">\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>Sharvil Patel, Managing Director:<\/strong>\u00a0Highlighted that the quarter reflected disciplined execution with most key businesses meeting expectations.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\">The company remains on track for FY26 aspirations and is optimistic about innovation-driven growth opportunities.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\">Focus continues on expanding presence in specialty segments, enhancing product portfolios, and improving operational efficiencies.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachLive\/5cbe5847-8d21-4622-bb0d-ead46665c984.pdf\" target=\"_blank\" rel=\"noopener\">R&amp;D investments<\/a> remain a priority for sustainable future growth, with recent product launches in key markets.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\">The company maintains high compliance standards while building pillars for long-term global growth.<\/p>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-170088\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7-839x1024.png\" alt=\"Zydus Lifesciences Q1 FY26 Earnings Results\" width=\"640\" height=\"781\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png 1489w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/p>\n<p>&nbsp;<\/p>\n<h2 id=\"q4-fy25-earnings-snapshot-januarymarch-2025\" class=\"mb-2 mt-4 text-base font-[500] first:mt-0 md:text-lg dark:font-[475] [hr+&amp;]:mt-4\">Q4 FY25 Earnings Results<\/h2>\n<ul class=\"marker:text-quiet list-disc\">\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">Zydus Lifesciences Ltd reported Revenues for Q4FY25 of \u20b96,528.00 Crores up from \u20b95,534.00 Crore year on year, a rise of 17.96%.<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">Total Expenses for Q4FY25 of \u20b94,717.00 Crores up from \u20b94,143.00 Crores year on year, a rise of 13.85%.<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">Consolidated Net Profit of \u20b91,244.00 Crores down 0.16% from \u20b91,246.00 Crores in the same quarter of the previous year.<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">The Earnings per Share is \u20b911.64, down 0.94% from \u20b911.75 in the same quarter of the previous year.<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\"><strong>EBITDA Margin:<\/strong>\u00a032.6%.<\/p>\n<\/li>\n<li class=\"py-0 my-0 prose-p:pt-0 prose-p:pb-2 prose-p:my-0 [&amp;&gt;p]:pt-0 [&amp;&gt;p]:pb-2 [&amp;&gt;p]:my-0\">\n<p class=\"my-0 py-2 [&amp;_strong:has(+br)]:inline-block [&amp;_strong:has(+br)]:pb-2\">The sequential growth in Q1 FY26 PAT by 25.3% reflects operational improvement and strategic execution.<\/p>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>To view the company&#8217;s previous earnings and latest concall transcripts, <a href=\"https:\/\/44.250.171.167\/symbol\/zyduslife\/\">click here<\/a>\u00a0 to visit the Alphastreet India news channel.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand promise of being dedicated to [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":170088,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,5747],"tags":[1115],"class_list":["post-170087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-healthcare-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/5-7.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":172227,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-q2-fy26-earnings-results\/","url_meta":{"origin":170087,"position":0},"title":"Zydus LifeSciences Q2 FY26 Earnings Results","author":"Chirag Gupta","date":"November 7, 2025","format":false,"excerpt":"In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Zydus LifeSciences Q2 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/Zydus-LifeSciences-Q2-FY26-Earnings-Results.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168476,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-ltd-q4fy25-0-fall-in-profits\/","url_meta":{"origin":170087,"position":1},"title":"Zydus Lifesciences Ltd Q4FY25; 0% fall in Profits","author":"Chirag Gupta","date":"May 21, 2025","format":false,"excerpt":"In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/3-10.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/3-10.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/3-10.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/3-10.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/3-10.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/3-10.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161303,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-ltd-q4fy24-248-rise-in-profits\/","url_meta":{"origin":170087,"position":2},"title":"Zydus Lifesciences Ltd Q4FY24; 248% rise in Profits","author":"Chirag Gupta","date":"May 17, 2024","format":false,"excerpt":"In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-134.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-134.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-134.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-134.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-134.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-134.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164412,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-ltd-q1fy24-97-rise-in-profits-2\/","url_meta":{"origin":170087,"position":3},"title":"Zydus Lifesciences Ltd Q1FY24; 97% rise in Profits","author":"Chirag Gupta","date":"September 18, 2024","format":false,"excerpt":"In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-63.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-63.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-63.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-63.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-63.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-63.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152931,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-ltd-q1fy24-97-rise-in-profits\/","url_meta":{"origin":170087,"position":4},"title":"Zydus Lifesciences Ltd Q1FY24; 97% rise in Profits","author":"Chirag Gupta","date":"August 11, 2023","format":false,"excerpt":"In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-750.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-750.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-750.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-750.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-750.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-750.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157516,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-ltd-q2fy24-53-rise-in-profits\/","url_meta":{"origin":170087,"position":5},"title":"Zydus Lifesciences Ltd Q2FY24; 53% rise in Profits","author":"Chirag Gupta","date":"December 20, 2023","format":false,"excerpt":"In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20. Adhering to its brand\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-164.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-164.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-164.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-164.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-164.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-164.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=170087"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170087\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/170088"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=170087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=170087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=170087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}